85 related articles for article (PubMed ID: 23900643)
21. A fully synthetic immunogen carrying a carcinoma-associated carbohydrate for active specific immunotherapy.
Lo-Man R; Bay S; Vichier-Guerre S; Dériaud E; Cantacuzène D; Leclerc C
Cancer Res; 1999 Apr; 59(7):1520-4. PubMed ID: 10197623
[TBL] [Abstract][Full Text] [Related]
22. [Experimental study on immunotherapy with dendritic cell in leukemic mice model].
Li XX; Chen XL; Ma DX; Liu CS; He XP
Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):73-7. PubMed ID: 16732955
[TBL] [Abstract][Full Text] [Related]
23. Fetal antigens in human leukemia.
Granatek CH; Hanna MG; Hersh EM; Gutterman JU; Mavligit GM; Candler EL
Cancer Res; 1976 Sep; 36(9 PT 2):3464-70. PubMed ID: 975105
[TBL] [Abstract][Full Text] [Related]
24. CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
Sandler AD; Chihara H; Kobayashi G; Zhu X; Miller MA; Scott DL; Krieg AM
Cancer Res; 2003 Jan; 63(2):394-9. PubMed ID: 12543793
[TBL] [Abstract][Full Text] [Related]
25. Reduction of human melanoma tumor growth in severe combined immunodeficient mice by passive transfer of antibodies induced by a high molecular weight melanoma-associated antigen mimotope vaccine.
Wagner S; Krepler C; Allwardt D; Latzka J; Strommer S; Scheiner O; Pehamberger H; Wiedermann U; Hafner C; Breiteneder H
Clin Cancer Res; 2008 Dec; 14(24):8178-83. PubMed ID: 19088033
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic CD3/CD28 cross-linked Th1 memory cells provide potent adjuvant effects for active immunotherapy of leukemia/lymphoma.
Har-Noy M; Zeira M; Weiss L; Fingerut E; Or R; Slavin S
Leuk Res; 2009 Apr; 33(4):525-38. PubMed ID: 18834631
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11.
Heimburg J; Yan J; Morey S; Glinskii OV; Huxley VH; Wild L; Klick R; Roy R; Glinsky VV; Rittenhouse-Olson K
Neoplasia; 2006 Nov; 8(11):939-48. PubMed ID: 17132226
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a proapoptotic antiganglioside GM2 monoclonal antibody and evaluation of its therapeutic effect on melanoma and small cell lung carcinoma xenografts.
Retter MW; Johnson JC; Peckham DW; Bannink JE; Bangur CS; Dresser K; Cai F; Foy TM; Fanger NA; Fanger GR; Woda B; Rock KL
Cancer Res; 2005 Jul; 65(14):6425-34. PubMed ID: 16024647
[TBL] [Abstract][Full Text] [Related]
29. Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.
Gabrilovich DI; Nadaf S; Corak J; Berzofsky JA; Carbone DP
Cell Immunol; 1996 May; 170(1):111-9. PubMed ID: 8665591
[TBL] [Abstract][Full Text] [Related]
30. Antibody-dependent cell cytotoxicity synapses form in mice during tumor-specific antibody immunotherapy.
Hubert P; Heitzmann A; Viel S; Nicolas A; Sastre-Garau X; Oppezzo P; Pritsch O; Osinaga E; Amigorena S
Cancer Res; 2011 Aug; 71(15):5134-43. PubMed ID: 21697279
[TBL] [Abstract][Full Text] [Related]
31. Induction of leukemia regression in mice by immunotherapeutic transfer of T-lymphocytes.
Johnson CS; Thurlow SM; Furmanski P
Cancer Res; 1986 Jan; 46(1):183-9. PubMed ID: 3079585
[TBL] [Abstract][Full Text] [Related]
32. B7-H1 protein vaccine induces protective and therapeutic antitumor responses in SP2/0 myeloma-bearing mice.
Zhang C; Wang W; Qin X; Xu Y; Huang T; Hao Q; Li W; Wu S; Zhang Y
Oncol Rep; 2013 Nov; 30(5):2442-8. PubMed ID: 23970300
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer.
Reinartz S; Hombach A; Köhler S; Schlebusch H; Wallwiener D; Abken H; Wagner U
Cancer Res; 2003 Jun; 63(12):3234-40. PubMed ID: 12810653
[TBL] [Abstract][Full Text] [Related]
34. Detection of a tumor-associated antigen on the surface of human myelogenous leukemia cells.
Malcolm AJ; Shipman RC; Levy JG
J Immunol; 1982 Jun; 128(6):2599-603. PubMed ID: 7042842
[TBL] [Abstract][Full Text] [Related]
35. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and immunological evaluation of an antitumor neoglycopeptide vaccine bearing a novel homoserine Tn antigen.
Vichier-Guerre S; Lo-Man R; Huteau V; Dériaud E; Leclerc C; Bay S
Bioorg Med Chem Lett; 2004 Jul; 14(13):3567-70. PubMed ID: 15177475
[TBL] [Abstract][Full Text] [Related]
37. Natural immunity to grafts of FLD-3 erythroleukemia cells by irradiated mice.
Afifi MS; Bennett M; Kumar V
Nat Immun Cell Growth Regul; 1986; 5(4):200-10. PubMed ID: 2430178
[TBL] [Abstract][Full Text] [Related]
38. Specificity of the passive antibody-induced suppression of the humoral immune response of mice to surface antigens on human cells.
Gadd SJ; Brogan MP; Ashman LK
Immunology; 1985 Feb; 54(2):223-31. PubMed ID: 2578428
[TBL] [Abstract][Full Text] [Related]
39. Leukemia cell-rhabdovirus vaccine: personalized immunotherapy for acute lymphoblastic leukemia.
Conrad DP; Tsang J; Maclean M; Diallo JS; Le Boeuf F; Lemay CG; Falls TJ; Parato KA; Bell JC; Atkins HL
Clin Cancer Res; 2013 Jul; 19(14):3832-43. PubMed ID: 23714728
[TBL] [Abstract][Full Text] [Related]
40. The expression on mouse lymphoid cells of Th-B, an antigen common to mouse B cells and thymus cells.
Yutoku M; Grossberg AL; Pressman D
J Immunol; 1975 Jul; 115(1):69-74. PubMed ID: 1097506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
